ASND (Ascendis Pharma AS) Other Current Liabilities: $606 Mil (As of Mar. 2026)


ASND Ascendis Pharma AS ASND
37 GF Score
Price $274.50
! 5 Warning Signs
View Full Analysis

What is Ascendis Pharma AS Other Current Liabilities?

Ascendis Pharma AS ASND +2.52% 37 Other Current Liabilities is $606 Mil as of Mar. 2026. GuruFocus rates ASND with a GF Score™ of 37/100. The stock has 5 warning signs investors should review.

Ascendis Pharma AS's other current liabilities for the quarter that ended in Mar. 2026 was $606 Mil.

Ascendis Pharma AS's quarterly other current liabilities increased from Sep. 2025 ($493 Mil) to Dec. 2025 ($563 Mil) and increased from Dec. 2025 ($563 Mil) to Mar. 2026 ($606 Mil).

Ascendis Pharma AS's annual other current liabilities increased from Dec. 2023 ($237 Mil) to Dec. 2024 ($333 Mil) and increased from Dec. 2024 ($333 Mil) to Dec. 2025 ($563 Mil).

Ascendis Pharma AS Other Current Liabilities Related Terms

Ascendis Pharma AS Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Ascendis Pharma AS's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Pharma AS Other Current Liabilities Chart

Ascendis Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.19 208.98 236.85 332.75 563.03

Ascendis Pharma AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 333.42 434.18 492.76 563.03 606.30
ASND
37GF Score
Ascendis Pharma AS ASND
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascendis Pharma AS Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $606 Mil mean?
Ascendis Pharma AS (ASND) has a Other Current Liabilities of $606 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ascendis Pharma AS.
Is Ascendis Pharma AS's Other Current Liabilities too high?
Ascendis Pharma AS's current Other Current Liabilities is $606 Mil. Overall, Ascendis Pharma AS has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Pharma AS's Other Current Liabilities compare to JAZZ and BBIO?
Ascendis Pharma AS's Other Current Liabilities of $606 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ascendis Pharma AS. Ascendis Pharma AS's current Other Current Liabilities is $606 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Pharma AS stock overvalued right now?
Ascendis Pharma AS (ASND) has a current Other Current Liabilities of $606 Mil. The current Other Current Liabilities is $606 Mil. Ascendis Pharma AS's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Ascendis Pharma AS (ASND), the current Other Current Liabilities is $606 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascendis Pharma AS Business Description

Other Exchanges A1SN34:Brazil
Address Tuborg Boulevard 12, Hellerup, DNK, 2900
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
37GF Score

Get the complete analysis for ASND

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$274.50
Price